Abstract
The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far. This article summarizes agents with potential efficacy against SARS-CoV-2.
Keywords
FavipiravirCoronavirus disease 2019 (COVID-19)CoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineDiseaseVirology2019-20 coronavirus outbreakChloroquinePandemicChinaBetacoronavirusVirusIntensive care medicineOutbreakInfectious disease (medical specialty)ImmunologyInternal medicineMalariaGeography
MeSH Terms
Adenosine MonophosphateAlanineAmidesAntiviral AgentsBetacoronavirusCOVID-19ChloroquineClinical Studies as TopicCoronavirus InfectionsDrug DiscoveryHumansIndolesPandemicsPneumoniaViralPyrazinesRibonucleotidesSARS-CoV-2Virus ReplicationCOVID-19 Drug Treatment
Affiliated Institutions
Related Publications
Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak that started in Wuhan, China, in 2019 resulted in a pandemic not seen for a century, and there is an ur...
Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation
The first case of human transmission of SARS-CoV-2 was reported in China in December 2019. A few months later, this viral infection had spread worldwide and became a pandemic. T...
Remdesivir for the Treatment of Covid-19 — Final Report
Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory trac...
Publication Info
- Year
- 2020
- Type
- article
- Volume
- 14
- Issue
- 1
- Pages
- 58-60
- Citations
- 1438
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1438
OpenAlex
63
Influential
981
CrossRef
Cite This
Liying Dong,
Shasha Hu,
Jianjun Gao
(2020).
Discovering drugs to treat coronavirus disease 2019 (COVID-19).
Drug Discoveries & Therapeutics
, 14
(1)
, 58-60.
https://doi.org/10.5582/ddt.2020.01012
Identifiers
- DOI
- 10.5582/ddt.2020.01012
- PMID
- 32147628